Needham analyst Mike Cikos lowered the firm’s price target on Varonis (VRNS) to $30 from $55 and keeps a Buy rating on the shares after its Q4 results. The firm expects Varonis to emerge from 2026 in a stronger position, but uncertainty over Non-SaaS ARR migrations, NRR expansion, and New Business are constraints in the near-term, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS: